No Data
No Data
Lanwei Medical (301060.SZ) announced first-quarter results, net profit of 1.071,700 yuan, a decrease of 95% year-on-year
Lanwei Medical (301060.SZ) released its report for the first quarter of 2024. The company achieved revenue during the reporting period...
The medical device sector declined at the beginning. Xiangyu Medical fell by more than 10%, while Beautiful Healthcare, Bohui Innovation, Aibang Healthcare, Lanwei Medicine, and Yangpu Healthcare followed suit.
The medical device sector declined at the beginning. Xiangyu Medical fell by more than 10%, while Beautiful Healthcare, Bohui Innovation, Aibang Healthcare, Lanwei Medicine, and Yangpu Healthcare followed suit.
Lanwei Medical (301060.SZ): A total cost of 15.3867 million yuan to buy back 1.1612,000 shares
Gelonghui, April 2, 丨 Lan Wei Medical (301060.SZ) announced that as of March 31, 2024, the company had repurchased a total of 1.1612 million shares through the Shenzhen Stock Exchange stock trading system, accounting for 0.29% of the company's current total share capital. The highest transaction price was 14.23 yuan/share, the minimum transaction price was 9.69 yuan/share, and the total transaction amount was RMB 15.3867 million (excluding transaction fees).
A-share afternoon review: Shanghai index rose 0.45%, leading the AIGC concept, medical services, and automotive sectors
Major A-share indices had mixed ups and downs. As of the midday close, the Shanghai Index rose 0.45% to 3076.67 points, the Shenzhen Stock Exchange Index fell 0.05%, and the GEM Index fell 0.16%.
Lanwei Medical (301060.SZ): A total cost of 14.9986 million yuan to buy back 0.28% of the shares
Gelonghui, Feb. 2: Lanwei Medical (301060.SZ) announced that as of January 31, 2024, the company had repurchased 1,121,200 shares of the company's shares through centralized bidding transactions through the Shenzhen Stock Exchange stock trading system, accounting for 0.28% of the company's current total share capital. The highest transaction price was 14.23 yuan/share, the minimum transaction price was 12.75 yuan/share, and the total transaction amount was RMB 14,998,563.00.
Express News | Lanwei Medical: Expected net loss of 110 million yuan to 165 million yuan in 2023, turning profit into loss
No Data